Join us to discover 4 of the world’s most innovative young diabetes companies and learn about the challenges they faced throughout their respective journeys from academia to where they are today.
Our top-notch speakers Sarah Ferber (Orgenesis), for saleYuval Avni (BetaO2), Mike Moradi (Sensulin) and Ignacio Faus (Genmedica) will share their experiences in this session chaired by: John Carroll, Editor-in-chief, FierceBiotech, USA
“The number of patients with type 1 and type 2 diabetes continues to increase, despite the world’s best efforts to diagnose/treat/cure the disease. This session, moderated by FierceBiotech’s John Carroll, will not be your average panel. Expect to hear the histories of 4 leading growth-stage diabetes companies, learn about next-generation therapies for T1D/T2D, and perhaps even be entertained with candid stories from three seasoned entrepreneurs.”
Mike Moradi, CEO, Sensulin, USA
The session will take place on November, 30th at 4PM, at Palais de la Musique et des Congres
Discover the full speaker list here, and the conference programme here.